YAP1 and renal carcinoma: Furthermore, molecules including Claudin‐2, SH3BGRL2, QKI, and REGγ/casein kinase 1ε (CK1ε) have also been demonstrated to exert critical regulatory functions in renal cancer progression through their interactions with the Hippo–YAP pathway.